Yes, with appropriate cold chain management
Studies report modulation of NO synthase activity and interaction with NO-mediated tissue protection pathways, which may underlie its broad cytoprotective profile
No placebo-controlled human trial was identified for weight management, diabetes, fatty liver disease, sarcopenia, athletic performance or healthy ageing
However, their significant logistical, psychiatric, and regulatory challenges remain a primary barrier
Glutathione Peroxidase / STransferase Assays Evaluate enzyme activity and inhibition in models of HO metabolism, organic peroxide reduction, and phase II detoxification of electrophiles